Filing Flows › VitaNova Life Sciences (VNOV) › Q4 FY26 › vs Q4 FY25
VitaNova Life Sciences (VNOV) Q4 FY26 vs Q4 FY25 (year over year)
VitaNova Life Sciences's revenue fell $168K (-9%) from $2.0M in Q4 FY25 to $1.8M in Q4 FY26.
VitaNova Life Sciences, Q4 FY26: revenue $1.8M (-9% year over year), operating margin -6.2%, net earnings $18K, operating cash flow $428K. The chart draws each line against Q4 FY25, the increases inside each band.
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $1.8M | $2.0M | −$168K | -9% |
| Income tax benefit | $125K | −$280K | $405K | — |
| Costs & expenses | $1.9M | $2.0M | −$41K | -2% |
| Operating costs | $1.9M | $871K | $1.0M | +118% |
| Net earnings | $18K | $800K | −$783K | -98% |
| Cost of revenue | $1.5M | $796K | $724K | +91% |
| General & admin | $328K | $30K | $299K | 11× |
| Other operating costs | $46K | $45K | $1K | +2% |
| Operating cash sources | $428K | $479K | −$51K | -11% |
| Share-based compensation | $179K | $0 | $179K | — |
| Working capital & other | $231K | −$321K | $553K | — |
| Operating cash flow | $428K | $479K | −$51K | -11% |
Questions
How much did VitaNova Life Sciences's revenue grow year over year in Q4 FY26?
VitaNova Life Sciences's revenue fell $168K (-9%) from $2.0M in Q4 FY25 to $1.8M in Q4 FY26.